Prognostic impact of primary Gleason pattern 5 in patients with low-volume metastatic hormone-sensitive prostate cancer treated with upfront ARPI-based doublet therapy: a real-world multicenter international collaborative study.

Yamada Y, Sato K, Luo HL, Wang HJ, Liu HY, Chang YL, Su YL, Wu CT, Yu KJ, Lin PH, Liu CY, Ho DR, Huang YC, Tsujino T, Saito S, Maenosono R, Nishimura K, Fukushima T, Nakamura K, Yamamoto S, Arai T, Sato H, Higuchi K, Kurozumi A, Takei A, Kanesaka M, Ando K, Kurokawa K, Kanaoka S, Takeshita N, Yoneda K, Hino D, Tamura T, Sazuka T, Imamura Y, Mikami K, Nakamura K, Fukasawa S, Naya Y, Nagata M, Komaru A, Tobe T, Suzuki N, Azuma H, Sakamoto S

Open source

DOI
10.1007/s10147-026-03240-7
Published
2026 Nov 6
Container
International journal of clinical oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10147-026-03240-7,
  title = {Prognostic impact of primary Gleason pattern 5 in patients with low-volume metastatic hormone-sensitive prostate cancer treated with upfront ARPI-based doublet therapy: a real-world multicenter international collaborative study.},
  author = {Yamada Y and Sato K and Luo HL and Wang HJ and Liu HY and Chang YL and Su YL and Wu CT and Yu KJ and Lin PH and Liu CY and Ho DR and Huang YC and Tsujino T and Saito S and Maenosono R and Nishimura K and Fukushima T and Nakamura K and Yamamoto S and Arai T and Sato H and Higuchi K and Kurozumi A and Takei A and Kanesaka M and Ando K and Kurokawa K and Kanaoka S and Takeshita N and Yoneda K and Hino D and Tamura T and Sazuka T and Imamura Y and Mikami K and Nakamura K and Fukasawa S and Naya Y and Nagata M and Komaru A and Tobe T and Suzuki N and Azuma H and Sakamoto S},
  year = {2026},
  journal = {International journal of clinical oncology},
  doi = {10.1007/s10147-026-03240-7},
  url = {https://doi.org/10.1007/s10147-026-03240-7}
}

RIS

TY  - JOUR
TI  - Prognostic impact of primary Gleason pattern 5 in patients with low-volume metastatic hormone-sensitive prostate cancer treated with upfront ARPI-based doublet therapy: a real-world multicenter international collaborative study.
AU  - Yamada Y
AU  - Sato K
AU  - Luo HL
AU  - Wang HJ
AU  - Liu HY
AU  - Chang YL
AU  - Su YL
AU  - Wu CT
AU  - Yu KJ
AU  - Lin PH
AU  - Liu CY
AU  - Ho DR
AU  - Huang YC
AU  - Tsujino T
AU  - Saito S
AU  - Maenosono R
AU  - Nishimura K
AU  - Fukushima T
AU  - Nakamura K
AU  - Yamamoto S
AU  - Arai T
AU  - Sato H
AU  - Higuchi K
AU  - Kurozumi A
AU  - Takei A
AU  - Kanesaka M
AU  - Ando K
AU  - Kurokawa K
AU  - Kanaoka S
AU  - Takeshita N
AU  - Yoneda K
AU  - Hino D
AU  - Tamura T
AU  - Sazuka T
AU  - Imamura Y
AU  - Mikami K
AU  - Nakamura K
AU  - Fukasawa S
AU  - Naya Y
AU  - Nagata M
AU  - Komaru A
AU  - Tobe T
AU  - Suzuki N
AU  - Azuma H
AU  - Sakamoto S
PY  - 2026
JO  - International journal of clinical oncology
DO  - 10.1007/s10147-026-03240-7
UR  - https://doi.org/10.1007/s10147-026-03240-7
ER  -

APA

Y, Y., K, S., HL, L., HJ, W., HY, L., YL, C., YL, S., CT, W., KJ, Y., PH, L., CY, L., DR, H., YC, H., T, T., S, S., R, M., K, N., T, F., K, N., S, Y., T, A., H, S., K, H., A, K., A, T., M, K., K, A., K, K., S, K., N, T., K, Y., D, H., T, T., T, S., Y, I., K, M., K, N., S, F., Y, N., M, N., A, K., T, T., N, S., H, A., & S, S. (2026). Prognostic impact of primary Gleason pattern 5 in patients with low-volume metastatic hormone-sensitive prostate cancer treated with upfront ARPI-based doublet therapy: a real-world multicenter international collaborative study.. International journal of clinical oncology. https://doi.org/10.1007/s10147-026-03240-7

Source records